As such, Gal-9 might be involved in the inflammatory cascade and indirectly compromises anti-tumor immunity by depleting polyfunctional CD26+CD8+ T cells in CLL. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.